Vor Ort
Merkzettel Warenkorb
  • Produktbild: Cardiac Markers
  • Produktbild: Cardiac Markers
- 12%

Cardiac Markers

Aus der Reihe Pathology and Laboratory Medicine
12% sparen

187,99 € UVP 213,99 €

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

12.06.2003

Abbildungen

107 schwarzweisse Abbildungen, 7 Abbildungenton-Abb., 100 schwarzweisse Zeichnungen 254 mm

Herausgeber

Alan H. B. Wu

Verlag

Humana Press

Seitenzahl

467

Maße (L/B/H)

26/18,3/3,1 cm

Gewicht

1107 g

Auflage

2nd edition 2003

Sprache

Englisch

ISBN

978-1-58829-036-6

Beschreibung

Rezension

"addresses the need in a variety of disciplines for an understanding of the evolving role of cardiac markers, particularly in relation to the diagnosis and treatment of acute coronary syndromes. The book provides a concise and informative summary of a rapidly developing field and will be a useful addition to the book-shelves of clinical pathologists, emergency physicians, and cardiologists." -New England Journal of Medicine

"...a valuable addition to the compendium of laboratory medicine literature on diagnostic tests and their appropriate clinical application...highly recommended for any individual interested in the state-of-the-art of appropriate laboratory assessment of the acute coronary syndrome patient." -Doody's Health Sciences Book Review Journal

"This comprehensive book not only offers physicians a complete guide to the use of cardiac markers in clinical practice, but also provides clinical laboratories with detailed information on the new markers which are now becoming standard." - Clinical Laboratory International

"...highly recommended as a reference resource for cardiologists, internists, emergency medicine physicians, and laboratory medicine physicians who have specific questions regarding the many clinically relevant cardiac markers...will save the physician considerable time and effort in answering a specific question that he or she may have within this rapidly evolving field." - Texas Heart Institute Journal

From reviews of the first edition...
"...provides a concise and informative summary of a rapidly developing field and will be a useful addition to the bookshelves of clinical pathologists, emergency physicians, and cardiologists." -New England Journal of Medicine

"...a valuable addition to the compendium of laboratory medicine literature on diagnostic tests and their appropriate clinical application...highly recommendedfor any individual interested in the state-of-the-art of appropriate laboratory assessment of the acute coronary syndrome patient." -Doody's Health Sciences Book Review Journal

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

12.06.2003

Abbildungen

107 schwarzweisse Abbildungen, 7 Abbildungenton-Abb., 100 schwarzweisse Zeichnungen 254 mm

Herausgeber

Alan H. B. Wu

Verlag

Humana Press

Seitenzahl

467

Maße (L/B/H)

26/18,3/3,1 cm

Gewicht

1107 g

Auflage

2nd edition 2003

Sprache

Englisch

ISBN

978-1-58829-036-6

Herstelleradresse

Springer-Verlag GmbH
Tiergartenstr. 17
69121 Heidelberg
DE

Email: ProductSafety@springernature.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
  • Produktbild: Cardiac Markers
  • Produktbild: Cardiac Markers
  • Part I. Cardiac Markers in Clinical Practice

    Early Detection of Myocardial Necrosis in the Emergency Setting and Utility of Serum Biomarkers in Chest Pain Unit Protocols

    Andra L. Blomkalns and W. Brian Gibler

    Management of Acute Coronary Syndromes

    Constantine N. Aroney and James A. de Lemos

    Evolution of Cardiac Markers in Clinical Trials

    Alexander S. Ro and Christopher R. deFilippi

    Assessing Reperfusion and Prognostic Infarct Sizing with Biochemical Markers: Practice and Promise

    Robert H. Christenson and Hassan M. E. Azzazy

    The Use of Cardiac Biomarkers to Detect Myocardial Damage Induced by Chemotherapeutic Agents

    Eugene H. Herman, Steven E. Lipshultz, and Victor J. Ferrans

    The Use of Biomarkers to Provide Diagnostic and Prognostic Information Following Cardiac Surgery

    Jesse E. Adams, III

    Part II. Clinical Use for Cardiac Troponins

    Cardiac Troponins: Exploiting the Diagnostic Potential of Disease-Induced Protein Modifications

    Ralf Labugger, D. Kent Arrell, and Jennifer E. Van Eyk

    Cardiac Troponin Testing in Renal Failure and Skeletal Muscle Disease Patients

    Fred S. Apple

    Cardiac-Specific Troponins Beyond Ischemic Heart Disease

    David Morrow

    Part III. Analytical Issues for Cardiac Markers

    Antibody Selection Strategies in Cardiac Troponin Assays

    Alexei Katrukha

    Interferences in Immunoassays for Cardiac Troponin

    Kiang-Teck J. Yeo and Daniel M. Hoefner

    Cardiac Marker Measurement by Point-of-Care Testing

    Paul O. Collinson

    Standardization of Cardiac Markers

    Mauro Panteghini

    Analytical Issues and the Evolution of Cutoff Concentrations for Cardiac Markers

    Alan H. B. Wu

    Part IV. Early Cardiac Markers of Myocardial Ischemia and Risk Stratification

    Rationale for the Early Clinical Application of Markers of Ischemia in Patients with Suspected Acute Coronary Syndromes

    Robert L. Jesse

    Ischemia-Modified Albumin, Free Fatty Acids, Whole Blood Choline, B-Type Natriuretic Peptide, Glycogen Phosphorylase BB, and Cardiac Troponin

    Alan H. B. Wu, Peter Crosby, Gary Fagan, Oliver Danne, Ulrich Frei, Martin Möckel, and Joseph Keffer

    C-Reactive Protein for Primary Risk Assessment

    Gavin J. Blake and Paul M. Ridker

    Prognostic Role of Plasma High-Sensitivity C-Reactive Protein Levels in Acute Coronary Syndromes

    Luigi M. Biasucci, Antonio Abbate, and Giovanna Liuzzo

    Preanalytic and Analytic Sources of Variations in C-Reactive Protein Measurement

    Thomas B. Ledue and Nader Rifai

    Fatty Acid Binding Protein as an Early Plasma Marker of Myocardial Ischemia and Risk Stratification

    Jan F. C. Glatz, Roy F. M. van der Putten, and Wim T. Hermens

    Oxidized Low-Density Lipoprotein and Malondialdehyde-Modified Low-Density Lipoprotein in Patients with Coronary Artery Disease

    Paul Holvoet

    Part V. Cardiac Markers of Congestive Heart Failure

    Pathophysiology of Heart Failure

    Johannes Mair

    B-Type Natriuretic Peptide: Biochemistry and Measurement

    Jeffrey R. Dahlen

    B-Type Natriuretic Peptide in the Diagnoses and Management of Congestive Heart Failure

    Ramin Tabbibizar and Alan Maisel

    Monitoring Efficacy of Treatment with Brain Natriuretic Peptide

    Emil D. Missov and Leslie W. Miller

    N-Terminal Pro-B-Type Natriuretic Peptide

    Torbjørn Omland and Christian Hall

    Part VI. Role of Infectious Diseases and Genetics in Heart Disease

    Infectious Diseases in the Etiology of Atherosclerosis and Acute Coronary Syndromes: Focus on Chlamydia pneumoniae

    Martin Möckel

    Polymorphisms Related to Acute Coronary Syndromes and Heart Failure: Potential Targets for Pharmacogenomics

    Alan H. B. Wu

    Index